title: [Myasthenia during interferon alpha therapy].
authors.forename: R
authors.initials: R
authors.lastname: Quilichini
authors.forename: F
authors.initials: F
authors.lastname: Mazzerbo
authors.forename: D
authors.initials: D
authors.lastname: Baume
authors.forename: O
authors.initials: O
authors.lastname: Amiel
authors.forename: A
authors.initials: A
authors.lastname: Lafeuillade
authors.forename: P
authors.initials: P
authors.lastname: Pellegrino
mesh_terms: D000368:Aged; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006526:Hepatitis C / Q000188:drug therapy; D006521:Hepatitis, Chronic / Q000188:drug therapy; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha
vernacular_title: Myasthénie au cours d'un traitement par l'interféron alpha.